Astegolimab or Efmarodocokin Alfa in Patients with Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial∗

Michael Waters, James A. McKinnell, Andre C. Kalil, Greg S. Martin, Timothy G. Buchman, Wiebke Theess, Xiaoying Yang, Annemarie N. Lekkerkerker, Tracy Staton, Carrie M. Rosenberger, Rajita Pappu, Yehong Wang, Wenhui Zhang, Logan Brooks, Dorothy Cheung, Joshua Galanter, Hubert Chen, Divya Mohan, Melicent C. Peck*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Astegolimab or Efmarodocokin Alfa in Patients with Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial∗'. Together they form a unique fingerprint.

Medicine & Life Sciences